RT Journal Article SR Electronic T1 The Phenome-wide Consequences of Anorexia Nervosa Genes JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2021.02.12.21250941 DO 10.1101/2021.02.12.21250941 A1 Jessica S. Johnson A1 Alanna C. Cote A1 Amanda Dobbyn A1 Laura G. Sloofman A1 Jiayi Xu A1 Liam Cotter A1 Alexander W. Charney A1 Eating Disorders Working Group of the Psychiatric Genomics Consortium A1 Jennifer Jordan A1 Martin Kennedy A1 Mikael Landén A1 Nicholas G Martin A1 Preben Bo Mortensen A1 Cynthia M. Bulik A1 Laura M. Huckins YR 2021 UL http://medrxiv.org/content/early/2021/02/18/2021.02.12.21250941.abstract AB Anorexia nervosa (AN) is a psychiatric disorder with complex etiology, with a significant portion of disease risk imparted by genetics. Traditional GWAS studies produce principal evidence for the association of genetic variants with disease, and provide a jumping-off point for downstream functional analyses. Transcriptomic imputation (TI) allows for the translation of SNPs into regulatory mechanisms, which can then be used to assess the functional outcome of genetically regulated gene expression (GReX) in a more broad setting through the use of phenome-wide association studies (PheWAS) in large and diverse clinical biobank populations with electronic health record (EHR) phenotypes. Here, we applied TI using S-PrediXcan to translate the most recent PGC-ED AN GWAS findings into AN-GReX. For significant genes, we imputed AN-GReX in the Mount Sinai BioMe™ Biobank and performed PheWAS on over 2000 clinical outcomes to test the clinical consequences of aberrant expression of these genes. We performed a secondary analysis to assess the impact of BMI on AN-GReX clinical associations.Our S-PrediXcan analysis identified 47 genes associated with AN, including what is, to our knowledge, the first genetic association of AN with the Major Histocompatibility Complex (MHC). AN-GReX was associated with autoimmune, anthropometric, metabolic, psychiatric and gastrointestinal diagnoses in our biobank cohort, as well as measures of anthropometry, substance use, and pain score. Our analyses reveal that AN-GReX associations with measures of weight and substance use are modified by BMI, and indicate potential avenues of functional mechanism to investigate further.Competing Interest StatementCM Bulik reports: Shire (grant recipient, Scientific Advisory Board member); Idorsia (consultant); Pearson (author, royalty recipient).Funding StatementJJ and LMH were supported by funding from the Klarman Family Foundation (2019 Eating Disorders Research Grants Program) and the NIMH (R01MH118278). CMB is supported by NIMH (R01MH120170; R01MH119084; R01MH118278; U01 MH109528); Brain and Behavior Research Foundation Distinguished Investigator Grant; Swedish Research Council (Vetenskapsradet, award: 538-2013-8864); Lundbeck Foundation (Grant no. R276-2018-4581).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Founded in September 2007, BioMe(TM) is a biobank that links genetic and electronic medical record (EMR) data for over 30,000 individuals recruited primarily in ambulatory care settings in the Mount Sinai Health System (MSHS) in New York City. The current study was approved by the Icahn School of Medicine at Mount Sinai Institutional Review Board (Institutional Review Board 07-0529). All study participants provided written informed consent.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSummary data is made available in the supplementary tables of this article.